Christian Klein, PhD

Chief Scientific Officer at Biotech Start-Up

Speaker

Christian Klein is specialized in the discovery, engineering and preclinical development of (bispecific) mAbs for immunotherapy. He is CSO & co-founder of a biotech startup. Previously, he was CXO & Drug Maker @Curie.Bio working with founders of seed stage biotechs. As a distinguished scientist, research project/program leader & mentor he made key contributions during 22 years @Roche pRED to the preclinical development of GAZYVA, VABYSMO and COLUMVI and 26 bsAbs, antibody-FPs and immunocytokines entering the clinic. He lead teams developing CrossMab®, 2+1 TCB, 4-1BB/CD28 costims, (PD1-cis) immunocytokines, next gen biologics, PRIT, P329G-CAR®-T platforms, and contributed to research on the IGF-1R mAb TEPEZZA and Nutlin MDM2i. He is a lecturer for biochemistry at LMU Munich since 2017, contributed to 240 publications and 250 patent families and is a Clarivate's Highly Cited Researcher 2024 & 2025.